References
- Danziger G, Hofmann A F, Schoenfield L J, Thistle J L. Dissolution of cholesterol gallstones by cheno-deoxycholic acid. N Engl J Med 1972; 286: 1–4
- Bell G D, Whitney B, Dowling R H. Gallstone dissolution in man using chenodeoxycholic acid. Lancet 1972; 2: 1213–1216
- Nakano Y, Nakano K. Some cases of gallstone dissolved by bile acid preparations. J Natl Council Commun Hosp 1973; 70: 25–32
- Erlinger S, Go A L, Hussen J M, Fevery J. Franco-Belgian cooperative study of ursodeoxycholic acid in medical dissolution of gallstones: a double-blind, randomised, dose-response study, and comparison with chenodeoxycholic acid. Hepatology 1984; 4: 308–314
- Howard P J, Gleeson D, Murphy G M, Dowling R H. Ursocholic acid: bile acid and bile lipid dose response and clinical studies in patients with gall stones. Gut 1989; 30: 97–103
- Podda M, Zuin M, Battezzati P M, Ghezzi C, Fazio C D, Dioguardi M L. Efficacy and safety of a combination of chenodeoxycholic acid and ursodeoxy-cholic acid for gallstone dissolution; a comparison with ursodeoxycholic acid alone. Gastroenter-ology 1989; 96: 222–229
- Roehrkasse R, Fromm H, Malavolti M, Tunuguntla A K, Ceryak S. Gallstone dissolution treatment with a combination of chenodeoxycholic and ursodeoxycholic acids. Studies of safety, efficacy and effects on bile lithogenicity, bile acid pool and serum lipids. Dig Dis Sci 1986; 10: 1032–1040
- Bellentani S, Tabarroni G, Barchi R, et al. Effect of ursodeoxycholic acid treatment on alanine amino-transferase and gamma-glutamyltranspeptidase serum levels in patients with hypertransaminasemia. Results from a double-blind controlled trial. J Hepa-tol 1989; 8: 7–12
- Juengst D, Brenner G, Pratschke E, Paumgartner G. Low-dose ursodeoxycholic acid prolongs cholesterol nucleation time in gallbladder bile of patients with cholesterol gallstones. J Hepatol 1989; 8: 1–6
- Tazuma S, Sasaki H, Mizuno S, et al. Effect of ursodeoxycholic acid administration on nucleation time in human gallbladder bile. Gastoenterology 1989; 97: 173–178
- Henderson J. Ursodeoxycholate treatment and postulated mechanism of calcification of previously radiolucent gall stones. Gut 1987; 28(10)A1385
- Knyrim K, Vakil N, Pfab R, Classen M. The effects of intraduodenal bile acid administration on biliary secretion of ionized calcium and carbonate in man. Hepatology 1989; 10: 134–142
- Sylwestrowicz T A, Shaffter E A. Gallbladder function during gallstone dissolution. Effect of bile acid therapy in patients with gallstones. Gastroen-terology 1988; 95: 740–748
- Hood K, Glesson D, Murphy G M, Dowling R H. Bile lipid and gall stone (GS) dissolution responses to combined chenodeoxycholic acid (CDCA) and ursodeoxycholic acid (UDCA) treatment. Gut 1987; 28(10)A1360
- Roda E, Bazzoli F, Mazzella G, Festi D, Villanova N, Ronchi M. Oral bile acid treatment for cholesterol gallstones. Acta Gastroenterol Belg 1988; 51: 244–249
- van Erpecum K J, Van Berge Henegouwen G P, van der Werf S D J. Gallstone dissolution treatment using cholelitholic bile acids: experience with 24 patients. Nether J Med 1989; 34: 3–9
- Holan K R, Holzbach R T, Herrmann R E, Cooperman A M, Claffey W J. Nucleation time: a key factor in the pathogenesis of cholesterol gallstone disease. Gastroenterology 1979; 77: 611–617
- Swobodnik W, Klüppelberg U, Wechsler J G, Volz M, Normandin G, Ditschuneit H. Rapid and accurate reversed-phase high-performance liquid chro-matographic determination of conjugated bile acids in human bile for routine clinical application. Therapeutic control during gallstone dissolution therapy. J Chromatography 1985; 339: 263–271
- Admirand W H, Small D H. The physicochemical basis of cholesterol gallstone formation in man. J Clin Invest 1968; 47: 1043–1052
- Kuroki S, Cohen I B, Carey M C, Mosbach E H. Rapid computation with the personal computer of the percent cholesterol saturation of bile samples. J Lip Res 1986; 27: 442–446
- Kibe A, Dudley M A, Halpern Z, Lynn M P, Breuer A C, Holzbach T. Factors affecting cholesterol monohydrat crystal nucleation time in model systems of supersaturated bile. J Lip Res 1985; 26: 1102–1111
- van Erpecum K J, van Berge Henegouwen G P, Stoelwinder B, Stolk M F J, Eggink W F, Goavaert W H A. Cholesterol and pigment gallstone disease: comparison of the reliability of three bile tests for differentiation between the two stone types. Scand J Gasteroenterol 1988; 23: 948–945
- Janowitz P, Swobodnik W, Wechsler J G, Zöller A, Kuhn K, Ditschuneit H. A comparison of gallbladder bile and endoscopically obtained duodenal bile. Gut 1991, (in press)
- Trotman B W, Ostrow J D, Soloway R D. Pigment vs cholesterol cholelithiasis: comparison of stone and bile composition. Am J Dig Dis 1974; 19: 585–590
- Akiyoshi T, Nakayama F. Bile acid composition in brown pigment stones. Dig Dis Sci 1990; 35: 27–32
- Marcus S N, Heaton K W. Effects of a new, concentrated wheat fibre preparation on intestinal transit, deoxycholic acid metabolism and the composition of bile. Gut 1986; 27: 893–900
- Marcus S N, Heaton K W. Intestinal transit, deoxycholic acid and the cholesterol saturation of bile: three inter-related factors. Gut 1986; 27: 550–558